SARS-CoV-2 S protein activates the HIV latent reservoir through the mTOR pathway
Xu, L.; Shi, H.; Chen, L.; Wang, H.; Shi, H.; Miao, X.; Li, S.; Jiang, Y.
Show abstract
During the global COVID-19 pandemic, mRNA vaccines using the S protein as antigen were widely used.Vaccine-induced S proteins can persist in vivo for weeks, triggering low-level immune activation. HIV latent reservoir maintenance is a major challenge for ART therapy, especially when immune pressure is waning. This then raises critical questions for HIV-infected patients: does prolonged exposure to S proteins affect HIV latent reservoir stability? Recent studies have pointed out that S proteins may activate the mTOR signaling pathway, which in turn affects the immune response and metabolic processes of cells. And the mTOR pathway is closely related to the maintenance and activation of HIV latent reservoir. However, how S proteins affect the HIV latent reservoir and the mechanism of activation are unclear. To explore the mechanism of how SARS-CoV-2 S proteins regulate the HIV latent reservoir and to explore whether S proteins regulate the HIV latent reservoir through the mTOR pathway, we constructed an in vitro HIV latent reservoir model for our experiments.To evaluate the potential role of S protein in HIV latent reservoir activation, relevant markers of HIV latent reservoir activation were detected using ELISA, flow cytometry, and RT-qPCR; and the relationship between S protein and mTOR was also detected by WB, CO-IP, and IFC.It was found that S proteins activated the HIV latent reservoir while increasing mTOR expression. It was further observed that mTOR inhibitors significantly inhibited S protein-induced activation of the HIV latent reservoir, and mTOR activators reversed the inhibitory effect of mTOR inhibitors on HIV latent reservoir activation. In summary, we found that S proteins activated the HIV latent reservoir through the mTOR pathway. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=170 SRC="FIGDIR/small/670887v1_ufig1.gif" ALT="Figure 1"> View larger version (48K): org.highwire.dtl.DTLVardef@f6d87aorg.highwire.dtl.DTLVardef@1fe4cc0org.highwire.dtl.DTLVardef@60eefeorg.highwire.dtl.DTLVardef@1ea9a34_HPS_FORMAT_FIGEXP M_FIG S protein interacts with mTOR and activates the mTOR-p-p70S6K-pS6 pathway, which promotes HIV transcription C_FIG
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Keap1 recognizes EIAV early accessory protein Rev to promote antiviral defense 95%
- Mechanistic insights and in vivo HIV suppression by the BRD4-targeting small molecule ZL0580 95%
- Merkel cell polyomavirus small tumor antigen contributes to immune evasion by interfering with type I interferon signaling 94%
Similar papers in this journal
- Mosquito defensins enhance Japanese encephalitis virus infection by facilitating virus adsorption and entry within mosquito 95%
- Enhanced transcriptional strength of HIV-1 subtype C minimizes gene expression noise and confers stability to the viral latent state 95%
- Modulation of Voltage-Gated Sodium Channel (VGSC) Activity in Human Dorsal Root Ganglion (DRG) Neurons by Herpesvirus Quiescent Infection 94%
Similar papers in this journal
- A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus 94%
- Mapping of single-cell landscape of acral melanoma and analysis of molecular regulatory network of tumor microenvironment 93%
- A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants 93%
Similar papers in this journal
- SARS-CoV-2 ORF9b Antagonizes Type I and III Interferons by Targeting Multiple Components of RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING Signaling Pathways 95%
- Key mutations on spike protein altering ACE2 receptor utilization and potentially expanding host range of emerging SARS-CoV-2 variants 95%
- Brilacidin, a COVID-19 Drug Candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E and NL63 through targeting both the virus and the host cell 94%
Similar papers in this journal
- Inhibition of BET family proteins suppresses African swine fever virus infection 95%
- The impact of early anti-SARS-CoV-2 antibody production on the length of hospitalization stay among COVID-19 patients 93%
- Characterization of the Kaposi's sarcoma-associated herpesvirus terminase complex component ORF29 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.